Get alerted on the PharmaSources E-Newsletter and Pharma Sources Insight E-Compilation!
Note: You can unsubscribe from the alerts at any time.
Advertising

Roivant Sciences and iNtRON Bio Sign Licensing Deal for Novel Anti-Superbugs Biologic SAL200

pharmafocusasiaNovember 22, 2018

Tag: iNtRON , Bacterial organism , SAL200

PharmaSources Customer Service